Pierre Mordant Selected Research

Extracorporeal Membrane Oxygenation

9/2023	Preventing Acute Limb Ischemia during VA-ECMO-In Silico Analysis of Physical Parameters Associated with Lower Limb Perfusion.
1/2020	Preclosing of the femoral artery allows total percutaneous venoarterial extracorporeal membrane oxygenation and prevents groin wound infection after lung transplantation.
9/2016	Esmolol Corrects Severe Hypoxemia in Patients with Femoro-Femoral Venoarterial Extracorporeal Life Support for Lung Transplantation.
1/2013	Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program).
7/2011	Extracorporeal membrane oxygenation in 5 patients with bronchial fistula with severe acute lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Mordant Research Topics

Disease

11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 09/2009
6	Neoplasms (Cancer) 04/2024 - 09/2009
6	Lung Neoplasms (Lung Cancer) 01/2017 - 02/2013
4	Fibrosis (Cirrhosis) 06/2023 - 01/2018
4	Infections 01/2022 - 04/2011
4	Neoplasm Metastasis (Metastasis) 09/2013 - 03/2011
3	Primary Graft Dysfunction 10/2023 - 01/2018
3	Wounds and Injuries (Trauma) 10/2023 - 06/2017
3	Hemorrhage 10/2023 - 10/2008
3	Idiopathic Pulmonary Fibrosis 10/2023 - 01/2016
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2023 - 01/2018
3	Pneumonia (Pneumonitis) 11/2022 - 03/2016
2	Lung Diseases (Lung Disease) 03/2024 - 11/2021
2	Hypoxia (Hypoxemia) 11/2023 - 09/2016
2	Cardiogenic Shock 09/2023 - 01/2013
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 07/2011
2	Virus Diseases (Viral Diseases) 01/2022 - 02/2020
2	Pneumothorax 01/2022 - 03/2016
2	COVID-19 12/2021 - 01/2021
2	Reperfusion Injury 11/2019 - 01/2018
2	Acute Lung Injury 11/2019 - 07/2011
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018 - 03/2016
2	Colorectal Neoplasms (Colorectal Cancer) 09/2013 - 09/2009
2	Adenocarcinoma 05/2013 - 03/2012
1	Pulmonary Hypertension 03/2024
1	Pulmonary Vein Stenosis 11/2023
1	Ischemia 09/2023
1	Sepsis (Septicemia) 01/2023
1	Airway Remodeling 01/2023
1	T-Cell Leukemia (Leukemia, T Cell) 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Asthma (Bronchial Asthma) 11/2021
1	Inflammation (Inflammations) 11/2021
1	Carcinoid Tumor (Carcinoid) 01/2021
1	Neuroendocrine Carcinoma 01/2021
1	Bacterial Infections (Bacterial Infection) 02/2020
1	Wound Infection (Wound Infections) 01/2020
1	Emphysema 11/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2019
1	Lung Injury 01/2018
1	Pulmonary Alveolar Proteinosis 01/2017
1	Bronchiolitis Obliterans Syndrome 01/2017
1	Malignant Mesothelioma 09/2016
1	Pulmonary Atelectasis 03/2016
1	Empyema 03/2016

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2013
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
2	Immune Checkpoint InhibitorsIBA 04/2024 - 02/2023
2	ErbB Receptors (EGF Receptor)IBA 03/2011 - 02/2010
1	HydrogelsIBA 04/2024
1	Antifibrotic AgentsIBA 10/2023
1	indium-bleomycinIBA 06/2023
1	Homeodomain Proteins (Proteins, Homeobox)IBA 06/2023
1	Transcription Factors (Transcription Factor)IBA 06/2023
1	Antisense OligonucleotidesIBA 06/2023
1	HDL CholesterolIBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	Colistin (Coly-Mycin)FDA Link 11/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	CollagenIBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2022
1	Immunoglobulin E (IgE)IBA 11/2021
1	Omalizumab (Xolair)FDA Link 11/2021
1	SteroidsIBA 11/2021
1	LipopolysaccharidesIBA 01/2021
1	InterleukinsIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	ChromatinIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019
1	human airway trypsin-like proteaseIBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Prostaglandins DIBA 01/2018
1	Calcineurin InhibitorsIBA 01/2018
1	Abatacept (Orencia)FDA Link 01/2018
1	Isoantigens (Alloantigen)IBA 01/2017
1	esmolol (Brevibloc)FDA LinkGeneric 09/2016
1	Extracellular Matrix ProteinsIBA 01/2016

Therapy/Procedure

16	Lung Transplantation 03/2024 - 11/2010
13	Therapeutics 10/2023 - 09/2009
8	Pneumonectomy (Lung Volume Reduction) 01/2017 - 02/2013
5	Extracorporeal Membrane Oxygenation 09/2023 - 07/2011
5	Thoracotomy 03/2016 - 10/2008
4	Drug Therapy (Chemotherapy) 01/2013 - 10/2008
3	Transplantation 03/2024 - 11/2010
3	Induction Chemotherapy 09/2016 - 02/2013
2	Length of Stay 01/2022 - 03/2016
2	Radiotherapy 01/2021 - 09/2016
1	Immunotherapy 04/2024
1	Perioperative Period 03/2024
1	Cannula 09/2023
1	Operative Surgical Procedures 12/2021
1	Robotic Surgical Procedures 12/2021
1	Bronchial Thermoplasty 11/2021
1	Thoracic Surgical Procedures 06/2017
1	Pleurodesis 03/2016
1	Lymph Node Excision (Lymph Node Dissection) 07/2014